These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus. Cao X, Shang QH, Chi XL, Zhang W, Xiao HM, Sun MM, Chen G, An Y, Lv CL, Wang L, Nan YM, Chen CY, Tan ZN, Liu XE, Zhuang H. World J Gastroenterol; 2020 Mar 14; 26(10):1067-1079. PubMed ID: 32205997 [Abstract] [Full Text] [Related]
4. [Relationship between hepatitis B surface antigen, HBV DNA quantity and liver fibrosis severity]. Gao Y, Zou G, Ye J, Pan G, Rao J, Li F, Wei Y, Li X. Zhonghua Gan Zang Bing Za Zhi; 2015 Apr 14; 23(4):254-7. PubMed ID: 26133815 [Abstract] [Full Text] [Related]
5. Serum microRNA-122 and Wisteria floribunda agglutinin-positive Mac-2 binding protein are useful tools for liquid biopsy of the patients with hepatitis B virus and advanced liver fibrosis. Nakamura M, Kanda T, Jiang X, Haga Y, Takahashi K, Wu S, Yasui S, Nakamoto S, Yokosuka O. PLoS One; 2017 Apr 14; 12(5):e0177302. PubMed ID: 28475652 [Abstract] [Full Text] [Related]
6. Serum microRNA-29 levels correlate with disease progression in patients with chronic hepatitis B virus infection. Huang C, Zheng JM, Cheng Q, Yu KK, Ling QX, Chen MQ, Li N. J Dig Dis; 2014 Nov 14; 15(11):614-21. PubMed ID: 25138057 [Abstract] [Full Text] [Related]
7. Fibro-indices versus liver stiffness for prediction of significant fibrosis in hepatitis B virus-infected Egyptian patients; a single-center experience. Said M, Eletreby R, Omar H, Dabees H, Abdelghafour R, El-Serafy M, Doss W. Expert Rev Gastroenterol Hepatol; 2020 Mar 14; 14(3):221-227. PubMed ID: 32031424 [Abstract] [Full Text] [Related]
12. The gamma-glutamyl transferase to platelet ratio and the FIB-4 score are noninvasive markers to determine the severity of liver fibrosis in chronic hepatitis B infection. Lee J, Kim MY, Kang SH, Kim J, Uh Y, Yoon KJ, Kim HS. Br J Biomed Sci; 2018 Jul 14; 75(3):128-132. PubMed ID: 29893189 [Abstract] [Full Text] [Related]
14. Serum miR-181b Is Correlated with Hepatitis B Virus Replication and Disease Progression in Chronic Hepatitis B Patients. Yu F, Zhou G, Li G, Chen B, Dong P, Zheng J. Dig Dis Sci; 2015 Aug 14; 60(8):2346-52. PubMed ID: 25976622 [Abstract] [Full Text] [Related]
15. Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy. Li N, Xu JH, Yu M, Wang S, Si CW, Yu YY. World J Gastroenterol; 2015 Nov 21; 21(43):12421-9. PubMed ID: 26604649 [Abstract] [Full Text] [Related]
16. Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection. Hsu CS, Liu WL, Chao YC, Lin HH, Tseng TC, Wang CC, Chen DS, Kao JH. Hepatol Int; 2015 Apr 21; 9(2):231-42. PubMed ID: 25788201 [Abstract] [Full Text] [Related]
17. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B. Hu YC, Liu H, Liu XY, Ma LN, Guan YH, Luo X, Ding XC. World J Gastroenterol; 2017 Nov 07; 23(41):7425-7432. PubMed ID: 29151696 [Abstract] [Full Text] [Related]
18. Evaluation of elastography combined with serological indexes for hepatic fibrosis in patients with chronic hepatitis B. Xu B, Zhou NM, Cao WT, Li XJ. World J Gastroenterol; 2018 Oct 07; 24(37):4272-4280. PubMed ID: 30310260 [Abstract] [Full Text] [Related]
19. Serum angiotensin-converting enzyme level for evaluating significant fibrosis in chronic hepatitis B. Noguchi R, Kaji K, Namisaki T, Moriya K, Kitade M, Takeda K, Kawaratani H, Okura Y, Aihara Y, Furukawa M, Mitoro A, Yoshiji H. World J Gastroenterol; 2017 Sep 28; 23(36):6705-6714. PubMed ID: 29085215 [Abstract] [Full Text] [Related]
20. Decreasing hepatitis B viral load is associated with a risk of significant liver fibrosis in hepatitis B e antigen positive chronic hepatitis B. Xie Q, Hu X, Zhang Y, Jiang X, Li X, Li J. J Med Virol; 2014 Nov 28; 86(11):1828-37. PubMed ID: 25145769 [Abstract] [Full Text] [Related] Page: [Next] [New Search]